Literature DB >> 9015212

Increased G-CSF responsiveness of bone marrow cells from hematopoietic cell phosphatase deficient viable motheaten mice.

P Tapley1, N K Shevde, P A Schweitzer, M Gallina, S W Christianson, I L Lin, R B Stein, L D Shultz, J Rosen, P Lamb.   

Abstract

The mouse mutation viable motheaten (me(v)) results in defects in the expression and catalytic activity of the cytoplasmic protein tyrosine phosphatase known as hematopoietic cell phosphatase (HCP). This reduction in HCP activity leads to the aberrant regulation of several myeloid and lymphoid cell lineages, including substantial increases in numbers of granulocytes. The differentiation, proliferation, and survival of cells in this lineage are normally supported by granulocyte-colony stimulating factor (G-CSF). In this study we have determined the consequences of the loss of HCP activity in me(v)/me(v) mice on the response of bone marrow cells to G-CSF. Bone marrow from these mice exhibited substantial increases in clonogenic and proliferative responses to G-CSF. These enhanced activities of G-CSF correlated with an increase in the level of immature granulocytic, G-CSF receptor positive cells in the bone marrow. These results suggested the possibility that HCP may regulate the G-CSF receptor by a direct interaction. However, under conditions where the previously described interaction between the erythropoietin receptor and HCP was readily observed, HCP did not detectably associate with the G-CSF receptor.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9015212

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  12 in total

1.  G-CSF receptor activation of the Src kinase Lyn is mediated by Gab2 recruitment of the Shp2 phosphatase.

Authors:  Muneyoshi Futami; Quan-Sheng Zhu; Zakary L Whichard; Ling Xia; Yuehai Ke; Benjamin G Neel; Gen-Sheng Feng; Seth J Corey
Journal:  Blood       Date:  2011-06-02       Impact factor: 22.113

2.  Normal neutrophil maturation is associated with selective loss of MAP kinase activation by G-CSF.

Authors:  Michael Baumann; Tricia Frye; Tahir Naqvi; Julian Gomez-Cambronero
Journal:  Leuk Res       Date:  2005-01       Impact factor: 3.156

Review 3.  Shp1 function in myeloid cells.

Authors:  Clare L Abram; Clifford A Lowell
Journal:  J Leukoc Biol       Date:  2017-06-12       Impact factor: 4.962

4.  T-cell protein tyrosine phosphatase (Tcptp) is a negative regulator of colony-stimulating factor 1 signaling and macrophage differentiation.

Authors:  Paul D Simoncic; Annie Bourdeau; Ailsa Lee-Loy; Larry R Rohrschneider; Michel L Tremblay; E Richard Stanley; C Jane McGlade
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

Review 5.  Investigations into the regulation and function of the SH2 domain-containing protein-tyrosine phosphatase, SHP-1.

Authors:  Florence W L Tsui; Alberto Martin; John Wang; Hing Wo Tsui
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 6.  The erythropoietin receptor: molecular structure and hematopoietic signaling pathways.

Authors:  Stephanie S Watowich
Journal:  J Investig Med       Date:  2011-10       Impact factor: 2.895

7.  Increased granulocyte colony-stimulating factor responsiveness but normal resting granulopoiesis in mice carrying a targeted granulocyte colony-stimulating factor receptor mutation derived from a patient with severe congenital neutropenia.

Authors:  M L McLemore; J Poursine-Laurent; D C Link
Journal:  J Clin Invest       Date:  1998-08-01       Impact factor: 14.808

Review 8.  Granulocyte colony-stimulating factor: molecular mechanisms of action during steady state and 'emergency' hematopoiesis.

Authors:  Athanasia D Panopoulos; Stephanie S Watowich
Journal:  Cytokine       Date:  2008-04-08       Impact factor: 3.861

Review 9.  The role and target potential of protein tyrosine phosphatases in cancer.

Authors:  Taolin Yi; Daniel Lindner
Journal:  Curr Oncol Rep       Date:  2008-03       Impact factor: 5.075

10.  The ITIM-containing receptor LAIR1 is essential for acute myeloid leukaemia development.

Authors:  Xunlei Kang; Zhigang Lu; Changhao Cui; Mi Deng; Yuqi Fan; Baijun Dong; Xin Han; Fuchun Xie; Jeffrey W Tyner; John E Coligan; Robert H Collins; Xiangshu Xiao; M James You; Cheng Cheng Zhang
Journal:  Nat Cell Biol       Date:  2015-04-27       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.